お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は変形性関節症の鎮痛剤市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは変形性関節症の鎮痛剤の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の変形性関節症の鎮痛剤市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは変形性関節症の鎮痛剤のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に変形性関節症の鎮痛剤市場を分類しています。本研究に含まれる主な企業は：Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Oral
    Injection
    External

用途別の市場セグメント：
    Medical Care
    Personal Care

本レポートの詳細内容
世界の変形性関節症の鎮痛剤市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、変形性関節症の鎮痛剤タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の変形性関節症の鎮痛剤収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の変形性関節症の鎮痛剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、変形性関節症の鎮痛剤市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

変形性関節症の鎮痛剤のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：変形性関節症の鎮痛剤のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：変形性関節症の鎮痛剤の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章変形性関節症の鎮痛剤企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：変形性関節症の鎮痛剤の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：変形性関節症の鎮痛剤の主要企業の概要を提供し、製品の説明と仕様、変形性関節症の鎮痛剤の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

Market Analysis and Insights: Global Drugs for Osteoarthritis Pain Market
The global Drugs for Osteoarthritis Pain market is projected to grow from US$ 9829.9 million in 2024 to US$ 13870 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Covers:
This report presents an overview of global market for Drugs for Osteoarthritis Pain market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Drugs for Osteoarthritis Pain, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Drugs for Osteoarthritis Pain, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drugs for Osteoarthritis Pain revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Drugs for Osteoarthritis Pain market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Drugs for Osteoarthritis Pain revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
    Pfizer
    Johnson & Johnson
    GlaxoSmithKline
    Bayer
    Eli Lilly
    Novartis
    Sanofi
    Horizon Pharma
    Abbott
    Mylan
    Daiichi Sankyo
    TEVA
    Almatica Pharma
    Astellas Pharma
    Tide Pharmaceutical
    Iroko Pharmaceuticals
    Hengrui Pharmaceutical
    Abiogen Pharma

Segment by Type
    Oral
    Injection
    External

Segment by Application
    Medical Care
    Personal Care

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Drugs for Osteoarthritis Pain in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Osteoarthritis Pain companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drugs for Osteoarthritis Pain revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Oral
    Table 3. Key Players of Injection
    Table 4. Key Players of External
    Table 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Drugs for Osteoarthritis Pain Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Drugs for Osteoarthritis Pain Market Share by Region (2019-2024)
    Table 9. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Drugs for Osteoarthritis Pain Market Share by Region (2025-2030)
    Table 11. Drugs for Osteoarthritis Pain Market Trends
    Table 12. Drugs for Osteoarthritis Pain Market Drivers
    Table 13. Drugs for Osteoarthritis Pain Market Challenges
    Table 14. Drugs for Osteoarthritis Pain Market Restraints
    Table 15. Global Drugs for Osteoarthritis Pain Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Drugs for Osteoarthritis Pain Revenue Share by Players (2019-2024)
    Table 17. Global Top Drugs for Osteoarthritis Pain by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2023)
    Table 18. Global Drugs for Osteoarthritis Pain Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Drugs for Osteoarthritis Pain Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Drugs for Osteoarthritis Pain, Headquarters and Area Served
    Table 21. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
    Table 22. Global Key Players of Drugs for Osteoarthritis Pain, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2019-2024)
    Table 26. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2025-2030)
    Table 28. Global Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2019-2024)
    Table 30. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Drugs for Osteoarthritis Pain Revenue Share by Application (2025-2030)
    Table 32. North America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Drugs for Osteoarthritis Pain Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Drugs for Osteoarthritis Pain Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Pfizer Company Details
    Table 65. Pfizer Business Overview
    Table 66. Pfizer Drugs for Osteoarthritis Pain Product
    Table 67. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 68. Pfizer Recent Developments
    Table 69. Johnson & Johnson Company Details
    Table 70. Johnson & Johnson Business Overview
    Table 71. Johnson & Johnson Drugs for Osteoarthritis Pain Product
    Table 72. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 73. Johnson & Johnson Recent Developments
    Table 74. GlaxoSmithKline Company Details
    Table 75. GlaxoSmithKline Business Overview
    Table 76. GlaxoSmithKline Drugs for Osteoarthritis Pain Product
    Table 77. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 78. GlaxoSmithKline Recent Developments
    Table 79. Bayer Company Details
    Table 80. Bayer Business Overview
    Table 81. Bayer Drugs for Osteoarthritis Pain Product
    Table 82. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 83. Bayer Recent Developments
    Table 84. Eli Lilly Company Details
    Table 85. Eli Lilly Business Overview
    Table 86. Eli Lilly Drugs for Osteoarthritis Pain Product
    Table 87. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 88. Eli Lilly Recent Developments
    Table 89. Novartis Company Details
    Table 90. Novartis Business Overview
    Table 91. Novartis Drugs for Osteoarthritis Pain Product
    Table 92. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 93. Novartis Recent Developments
    Table 94. Sanofi Company Details
    Table 95. Sanofi Business Overview
    Table 96. Sanofi Drugs for Osteoarthritis Pain Product
    Table 97. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 98. Sanofi Recent Developments
    Table 99. Horizon Pharma Company Details
    Table 100. Horizon Pharma Business Overview
    Table 101. Horizon Pharma Drugs for Osteoarthritis Pain Product
    Table 102. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 103. Horizon Pharma Recent Developments
    Table 104. Abbott Company Details
    Table 105. Abbott Business Overview
    Table 106. Abbott Drugs for Osteoarthritis Pain Product
    Table 107. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 108. Abbott Recent Developments
    Table 109. Mylan Company Details
    Table 110. Mylan Business Overview
    Table 111. Mylan Drugs for Osteoarthritis Pain Product
    Table 112. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 113. Mylan Recent Developments
    Table 114. Daiichi Sankyo Company Details
    Table 115. Daiichi Sankyo Business Overview
    Table 116. Daiichi Sankyo Drugs for Osteoarthritis Pain Product
    Table 117. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 118. Daiichi Sankyo Recent Developments
    Table 119. TEVA Company Details
    Table 120. TEVA Business Overview
    Table 121. TEVA Drugs for Osteoarthritis Pain Product
    Table 122. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 123. TEVA Recent Developments
    Table 124. Almatica Pharma Company Details
    Table 125. Almatica Pharma Business Overview
    Table 126. Almatica Pharma Drugs for Osteoarthritis Pain Product
    Table 127. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 128. Almatica Pharma Recent Developments
    Table 129. Astellas Pharma Company Details
    Table 130. Astellas Pharma Business Overview
    Table 131. Astellas Pharma Drugs for Osteoarthritis Pain Product
    Table 132. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 133. Astellas Pharma Recent Developments
    Table 134. Tide Pharmaceutical Company Details
    Table 135. Tide Pharmaceutical Business Overview
    Table 136. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product
    Table 137. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 138. Tide Pharmaceutical Recent Developments
    Table 139. Iroko Pharmaceuticals Company Details
    Table 140. Iroko Pharmaceuticals Business Overview
    Table 141. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product
    Table 142. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 143. Iroko Pharmaceuticals Recent Developments
    Table 144. Hengrui Pharmaceutical Company Details
    Table 145. Hengrui Pharmaceutical Business Overview
    Table 146. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product
    Table 147. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 148. Hengrui Pharmaceutical Recent Developments
    Table 149. Abiogen Pharma Company Details
    Table 150. Abiogen Pharma Business Overview
    Table 151. Abiogen Pharma Drugs for Osteoarthritis Pain Product
    Table 152. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2019-2024) & (US$ Million)
    Table 153. Abiogen Pharma Recent Developments
    Table 154. Research Programs/Design for This Report
    Table 155. Key Data Information from Secondary Sources
    Table 156. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Drugs for Osteoarthritis Pain Market Share by Type: 2023 VS 2030
    Figure 3. Oral Features
    Figure 4. Injection Features
    Figure 5. External Features
    Figure 6. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Drugs for Osteoarthritis Pain Market Share by Application: 2023 VS 2030
    Figure 8. Medical Care Case Studies
    Figure 9. Personal Care Case Studies
    Figure 10. Drugs for Osteoarthritis Pain Report Years Considered
    Figure 11. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Drugs for Osteoarthritis Pain Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Drugs for Osteoarthritis Pain Market Share by Region: 2023 VS 2030
    Figure 14. Global Drugs for Osteoarthritis Pain Market Share by Players in 2023
    Figure 15. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Osteoarthritis Pain as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2023
    Figure 17. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)
    Figure 19. North America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)
    Figure 20. North America Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)
    Figure 21. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)
    Figure 25. Europe Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)
    Figure 26. Europe Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)
    Figure 27. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)
    Figure 35. China Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)
    Figure 36. Asia Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)
    Figure 38. Asia Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)
    Figure 39. Asia Drugs for Osteoarthritis Pain Market Share by Region (2019-2030)
    Figure 40. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Drugs for Osteoarthritis Pain Market Share by Country (2019-2030)
    Figure 50. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Drugs for Osteoarthritis Pain Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 57. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 58. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 59. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 60. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 61. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 62. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 63. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 64. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 65. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 66. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 67. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 68. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 69. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 70. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 71. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 72. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 73. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed